Nimorazole

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nimorazole
Nimorazol.svg
Systematic (IUPAC) name
4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]morpholine
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
?
Identifiers
CAS number 6506-37-2
ATC code P01AB06 QP51AA06
PubChem CID 23009
ChemSpider 21533
UNII 469ULX0H4G YesY
KEGG D07352 YesY
Chemical data
Formula C9H14N4O3 
Mol. mass 226.23 g/mol
 YesY (what is this?)  (verify)

Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]

References[edit]

  1. ^ Roy, R. B.; Laird, S. M.; Heasman, L. (1975). "Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole". The British Journal of Venereal Diseases 51 (4): 281–284. PMC 1046566. PMID 1098732.  edit
  2. ^ Henk, J. M.; Bishop, K.; Shepherd, S. F. (2003). "Treatment of head and neck cancer with CHART and nimorazole: Phase II study". Radiotherapy and Oncology 66 (1): 65–70. doi:10.1016/S0167-8140(02)00284-0. PMID 12559522.  edit
  3. ^ ClinicalTrials.gov NCT01507467 IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck